UBS Group
ABVX

UBS Group’s Abivax ABVX Stock Holding History

UBS Group’s Portfolio ABVX Stock Details ABVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$506M Buy
4,547,406
+123,500
+3% +$14.6M 0.08% 268
2025
Q4 		$597M Sell
4,423,906
-37,356
-0.8% -$4.08M 0.1% 202
2025
Q3 		$379M Buy
4,461,262
+4,293,606
+2,561% +$263M 0.06% 317
2025
Q2 		$1.28M Buy
167,656
+5,102
+3% +$33.3K ﹤0.01% 5225
2025
Q1 		$1.02M Sell
162,554
-12,319
-7% -$83.4K ﹤0.01% 5277
2024
Q4 		$1.28M Buy
174,873
+174,182
+25,207% +$1.6M ﹤0.01% 5122
2024
Q3 		$7.96K Buy
+691
New +$8.28K ﹤0.01% 7863
2024
Q2 		– Sell
-3
Closed -$43 – 9461
2024
Q1 		$43 Buy
+3
New +$39 ﹤0.01% 8944

Other funds holding ABVX

TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
CP
Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
HI
Helikon Investments London, United Kingdom $2.65B AUM 79.03% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return